Skip to content

Role of Ayurveda medicine to manage chronic Kidney Disease

To evaluate the augmentative effect of Mutrakricchahar Arka and Mutravirechaniya Mahakashaya ghan vati with comtemporary medicine in Mutravaha Srotodushti Chronic Kidney Disease open labeled randomized clinical trial - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080293
Enrollment
60
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Sponsors

Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 18 or more then 18 years to 60 years. Sex both male and female with irrespective of gender. Patient diagnosed with sign and symptom of Chronic Kidney Disease as per standard KIDGO criteria. Patient with symptom of Mutravaha Srotodushti. Patient of diabetes Mellitus having controlled fasting blood sugar more then or equal to 200mg per dl post prandial blood sugar less then 300 mg per dl, HbA1c less then 7 having Chronic Kidney Disease symptoms with or without Hypertension or Type 2 Diabetes Mellitus. Patient undergoes Dialysis regularly more than 2 times in 7 days. Patients who are ready to give consent with firm home address and contact number which is readily

Exclusion criteria

Exclusion criteria: Age less then 18 and more then 60 yrs. Patients take insulin for blood glucose control. HbA1c more then 7 Blood Pressure 160 by 100 mmHg with medication Patient undergoes Dialysis regularly more than 2 times in 7 days . Urinary tract obstruction like benign prostatic hypertrophy , renal calculi tumors or disease such as HIV patient Hepatitis C Lactating mother Pregnant women Patient not able to take oral medicine Patient who are not willing to sign informed consent Patient who are registered in any research project

Design outcomes

Primary

MeasureTime frame
Improvement in eGFR after as per the KIDGO criteriaTimepoint: 4 weeks

Secondary

MeasureTime frame
Improvised Serum creatinine Serum blood urea Serum electrolyte Improvised sign and symptoms of Mutravaha Srotodushti Atisritum MutramPolyuria Ativibaddham Mutram Anuria Alpa-Alpa Mutra Oligouria Bahal Mutram Proteinuria Improvement in the quality of life. Timepoint: 30 days

Countries

India

Contacts

Public ContactJitendra Varsakiya

Chaudhary Brahm Prakash Ayurved Charak Sansthan

jeet12989@gmail.com9879158817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026